Bank Of America Corp Immunovant, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Immunovant, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 227,024 shares of IMVT stock, worth $6.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

227,024

Previous 243,334 6.7%

Holding current value

$6.25 Million

Previous $6.42 Million 2.79%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$27.51 - $27.51 $448,688 - $448,688	-16,310 Reduced 6.7%	227,024 $6.25 Million
Q2 2024 Aug 14, 2024	BUY	$25.1 - $31.61 $871,070 - $1.1 Million	34,704 Added 16.63%	243,334 $6.42 Million
Q1 2024 May 15, 2024	SELL	$30.27 - $43.79 $416,091 - $601,937	-13,746 Reduced 6.18%	208,630 $6.74 Million
Q4 2023 Feb 14, 2024	BUY	$31.31 - $44.19 $1.43 Million - $2.01 Million	45,516 Added 25.74%	222,376 $9.37 Million
Q2 2023 Aug 14, 2023	SELL	$14.2 - $23.75 $3.31 Million - $5.53 Million	-232,954 Reduced 56.84%	176,860 $3.36 Million
Q1 2023 May 12, 2023	BUY	$15.27 - $19.72 $2.67 Million - $3.45 Million	175,011 Added 74.54%	409,814 $6.36 Million
Q4 2022 Feb 10, 2023	BUY	$6.59 - $17.75 $1.38 Million - $3.72 Million	209,331 Added 821.81%	234,803 $4.17 Million
Q3 2022 Nov 14, 2022	BUY	$3.93 - $6.37 $43,418 - $70,375	11,048 Added 76.59%	25,472 $142,000
Q2 2022 Aug 12, 2022	SELL	$3.38 - $5.65 $39,691 - $66,347	-11,743 Reduced 44.88%	14,424 $56,000
Q1 2022 May 16, 2022	SELL	$5.06 - $8.77 $1.01 Million - $1.75 Million	-199,281 Reduced 88.39%	26,167 $144,000
Q4 2021 Feb 08, 2022	BUY	$7.33 - $9.32 $953,940 - $1.21 Million	130,142 Added 136.55%	225,448 $1.92 Million
Q3 2021 Nov 15, 2021	SELL	$7.01 - $11.37 $276,299 - $448,148	-39,415 Reduced 29.26%	95,306 $828,000
Q2 2021 Sep 13, 2021	BUY	$9.4 - $16.85 $1.27 Million - $2.27 Million	134,721 New	134,721 $1.43 Million

Others Institutions Holding IMVT

# of Institutions

211

Shares Held

66.9M

Call Options Held

2.3M

Put Options Held

631K

View Full List

About Immunovant, Inc.

Ticker IMVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,077,000
Market Cap $3.55B
Description
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...

More about IMVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Immunovant, Inc. Transaction History